Participants in the highest tertile of serum ghrelin had a significant lower risk of hypertriglyceridemia (P trend = 0.003), hyperglycemia (P trend = 0.021), Low HDL-C (P trend = 0.006), and MetS (P trend < 0.001) in both crude and adjusted models. Here, GHRL is linked to metabolic syndrome.